Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
ADCT on NYSE
Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA
Holdings reported by Redmile Group, LLC for ADC Therapeutics SA
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Shares, par value CHF 0.08 per share |
15,666,731 |
$59,690,245 |
$3.81 |
11 Dec 2024 |
Indirect |
|
|
| Common Shares, par value CHF 0.08 per share |
13,145,712 |
$50,085,163 |
$3.81 |
11 Dec 2024 |
Direct |
|
|
| Pre-Funded Warrants |
3,846,153 |
$14,999,996 |
$3.90 |
27 Oct 2025 |
Direct |
Common Share |
|
| Pre-Funded Warrants |
3,846,153 |
$14,999,996 |
$3.90 |
27 Oct 2025 |
Indirect |
Common Share |
|
Transactions reported by Redmile Group, LLC for ADC Therapeutics SA
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.